Aug. 11 at 3:57 PM
$NGVT narrows losses but faces revenue slump
Ingevity Corporation posted adjusted earnings of
$1.39 per share in Q2, better than the Zacks estimate of
$1.02, yet revenue fell 6.5% due to weak Performance Chemicals sales.
Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2697647/ingevity-q2-earnings-surpass-estimates-revenues-decline-yy?cid=sm-stocktwits-2-2697647-body-7184&ADID=SYND_STOCKTWITS_TWEET_2_2697647_BODY_7184